Delta, JPMorgan, BlackRock and many more

Check out the companies that made headlines hours ago:

Delta Air Lines (DAL) – Delta Premarket rose 6.6% after reporting expected quarterly losses and forecasting current-quarter profit. The airline added that monthly earnings exceeded pre-epidemic levels for the first time in March.

JPMorgan Chase (JPM) – The bank’s quarterly earnings per share stood at 63 2.63, a shy 6 cents, although revenue exceeded Wall Street forecasts. JPMorgan’s profit fell 42% year-on-year as deals slowed and trading earnings declined. The stock fell 1.1% in the primary market.

Bed Bath and Beyond (BBBY) – Household retailers reported a consistent quarterly loss of 92 cents per share, compared to analysts’ expectations of a 3-cent-per-share gain. Bed Bath & Beyond raised prices quarterly, but it was not enough to offset rising shipping costs and other adverse factors. Bed Bath & Beyond shares fell 8% in premarket trading.

BlackRock (BLK) – Asset management firm reported a consistent quarterly profit of $ 9.52 per share, compared to the $ 8.75 consensus estimate. Revenue was largely consistent with the forecast. It helped Blackrock increase its cash flow as its assets under management increased from just $ 9 trillion a year ago to $ 9.57 trillion.

Antares Pharma (ATRS) – The stock of specialized pharmaceutical companies rose 48.7% in trading after Halozyme Therapeutics (HALO) agreed to buy $ 960 million or $ 5.60 per share in cash.

PayPal Holdings (PYPL) – PayPal chief financial officer John Rainey is leaving the payment company to take a similar role in Walmart (WMT), effective June 6. Rainey will replace Brett Biggs, who has been CFO since 2015. PayPal premarket lost 3.5%.

Sierra Oncology (SRRA) – Drug developer GlaxoSmithKline (GSK) has agreed to buy it for 1.9 billion, its share in the premarket has risen 37.5%, while Glaxo shares have risen 1.1%.

Charles Schwab (SCHW) – Brokerage firm’s stock rose 1% in premarket trading, while Morgan Stanley called it a “top pick”, saying Schwab would benefit from a growing rate and an attractive valuation compared to his peers.

Leave a Reply

Your email address will not be published.